Does Timing of Cytoreductive Nephrectomy Impact Patient Survival With Metastatic Renal Cell Carcinoma in the Tyrosine Kinase Inhibitor Era? A Multi-institutional Study

Classification of Surgical Complications

2004 • 26,400 citations

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

2008 • 25,031 citations

AJCC Cancer Staging Manual

2016 • 16,972 citations

A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

1999 • 14,690 citations

Cancer Statistics, 2010

2010 • 12,557 citations

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1982 • 10,605 citations

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

2007 • 5,572 citations

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

2003 • 2,458 citations

Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

2001 • 1,690 citations

Renal cell carcinoma

2009 • 1,488 citations

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

2001 • 1,378 citations

Sunitinib in Patients With Metastatic Renal Cell Carcinoma

2006 • 1,204 citations

Mechanisms of adverse effects of anti-VEGF therapy for cancer

2007 • 914 citations

Pathology and genetics of tumours of the urinary system and male genital organs

2004 • 824 citations

Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs

2005 • 549 citations

Targeted Therapy for Metastatic Renal Cell Carcinoma

2006 • 437 citations

Survival after complete surgical resection of multiple metastases from renal cell carcinoma

2011 • 392 citations

The Impact of Cytoreductive Nephrectomy on Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Targeted Therapy

2010 • 344 citations

Response of the Primary Tumor to Neoadjuvant Sunitinib in Patients With Advanced Renal Cell Carcinoma

2008 • 189 citations

Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm

2008 • 161 citations

Surgical Morbidity Associated With Administration of Targeted Molecular Therapies Before Cytoreductive Nephrectomy or Resection of Locally Recurrent Renal Cell Carcinoma

2008 • 159 citations

Prospective Clinical Trial of Preoperative Sunitinib in Patients With Renal Cell Carcinoma

2010 • 128 citations

The Outcome of Patients Treated with Sunitinib Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer

2011 • 112 citations

Nephron-Sparing Surgery for Renal Cell Carcinoma: Detailed Analysis of Complications Over a 15-Year Period

2006 • 112 citations

EORTC-GU group expert opinion on metastatic renal cell cancer

2009 • 101 citations

Feasibility and efficacy of neoadjuvant sunitinib before nephron‐sparing surgery

2010 • 99 citations

Multimodal Approaches in the Management of Locally Advanced and Metastatic Renal Cell Carcinoma: Combining Surgery and Systemic Therapies to Improve Patient Outcome

2007 • 74 citations

Neoadjuvant (presurgical) therapy for renal cell carcinoma: A new treatment paradigm for locally advanced and metastatic disease

2009 • 65 citations

The Impact of Cytoreductive Nephrectomy on Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Targeted Therapy

2011 • 36 citations

Presurgical Targeted Therapy with Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma: Clinical Results and Histopathological Therapeutic Effects

2010 • 35 citations

1477 PROSPECTIVE CLINICAL TRIAL OF PREOPERATIVE SUNITINIB IN PATIENTS WITH RENAL CELL CARCINOMA

2010 • 19 citations

Clinical trial to assess the importance of nephrectomy

2012 • 3 citations

Deleted Work

1955 • 0 citations